Related Experiment Video
Updated: May 5, 2026

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine
Published on: May 21, 2012
Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease
S Schreiber1, R P MacDermott, A Raedler
1Gastrointestinal Section, University of Pennsylvania School of Medicine, Philadelphia.
Insights
Lymphocyte activation is heightened in inflammatory bowel disease (IBD), affecting all major immune cell types in the gut. This study developed a method to accurately measure this activation, revealing its role in IBD
Area of Science:
- Immunology
- Gastroenterology
Background:
- Normal human lamina propria lymphocytes exhibit heightened activation compared to peripheral blood, indicated by cell-surface activation antigen expression and immunoglobulin secretion.
- Inflammatory bowel disease (IBD) involves significant immunological alterations in the intestinal mucosa.
Purpose of the Study:
- To evaluate cell-surface expression of activation-associated antigens in colonic lamina propria mononuclear cell subpopulations in IBD.
- To develop and validate a method for accurate flow-cytometric analysis of intestinal lymphocytes, addressing autofluorescence.
Main Methods:
- Developed a computer-assisted method to subtract autofluorescence from flow cytometry data of intestinal lamina propria mononuclear cells.
- Utilized fluorescence-activated cell sorting with autofluorescence subtraction for single-cell analysis.
- Quantified expression of lymphocyte activation antigens (interleukin-2 receptor, transferrin receptor, 4F2) on B cells, T cells, CD4+ T cells, and CD8+ T cells.
Main Results:
- A novel method effectively removed autofluorescence, enhancing sensitivity and specificity in flow-cytometric analyses of intestinal lamina propria mononuclear cells.
- Significantly increased expression of lymphocyte activation antigens was observed on all investigated lymphocyte subpopulations (B cells, T cells, CD4+ T cells, CD8+ T cells) in both Crohn's disease and ulcerative colitis.
- 5-aminosalicylic acid demonstrated a dose-dependent inhibition of activation antigen expression on mitogen-activated peripheral blood lymphocytes.
Conclusions:
- Markedly increased intestinal lymphocyte activation is a key immunological feature across all studied lymphocyte subpopulations in IBD.
- Lymphocyte activation likely contributes to the chronicity and perpetuation of IBD.
- 5-aminosalicylic acid may exert therapeutic effects through the inhibition of lymphocyte activation.
Abstract:
Normal human lamina propria lymphocytes are in a heightened state of activation compared with peripheral blood with regard to cell-surface activation antigen expression (transferrin receptor, interleukin-2 receptor, 4F2) and the increased spontaneous secretion of immunoglobulins in vitro. This study evaluates the cell-surface expression of activation-associated antigens in different subpopulations of isolated colonic lamina propria mononuclear cells in inflammatory bowel disease. In pilot studies using three-color flow cytometry, autofluorescence was observed that was emitted by unstained lamina propria mononuclear cells, which interfered with both the sensitivity and the specificity of the analyses. Because a major portion of the intestinal lymphocyte populations of interest were autofluorescent, a method to remove autofluorescence signals was developed by designing a computer program for the subtraction of autofluorescence from the emissions of each individual cell. This technique increases both the sensitivity and specificity of flow-cytometric analyses of intestinal lamina propria mononuclear cells. Using fluorescence-activated cell-sorter analyses with subtraction of autofluorescence on a single-cell basis, increased expression of lymphocyte activation antigens (interleukin-2 receptor, transferrin receptor, 4F2) was found on the cell surface of isolated intestinal B cells, T cells, CD4+ T cells, and CD8+ T cells in both Crohn's disease and ulcerative colitis. Therefore, markedly increased intestinal lymphocyte activation is a major immunological alteration in inflammatory bowel disease and includes all lymphocyte subpopulations investigated in this study. In addition, 5-aminosalicylic acid, which is used for the treatment of intestinal inflammation in inflammatory bowel disease, inhibits the expression of cell-surface activation antigens on mitogen-activated peripheral blood lymphocytes in a dose-dependent manner. These observations suggest that lymphocyte activation may play an important role in underlying immune processes that lead to chronicity and perpetuation of inflammatory bowel disease and may implicate an additional mechanism for the therapeutic action of 5-aminosalicylic acid.
Related Concept Videos
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

